Valence 로고
인기
로그인
Loading data for WALDW — first visit, this takes a few seconds.

관심목록에 추가

Waldencast

NasdaqCM: WALDW · 실시간 가격 · USD
0.03
+0.00 (0.00%)
종가 기준: Aug 24, 2026, 2:20 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

Waldencast(WALDW) 주가, 분석 및 데이터

0.00%

데이터 없음

매수호가0.81
시가총액n/a
매출 (ttm)272.07M
순이익 (ttm)-229.75M
-0.04
n/a
n/a
n/a
P/B (ttm)0.01
P/S (ttm)n/a
실적 발표일n/a
매도호가1.09
거래량409
평균 거래량 (20일)42,149
시가0.86
전일 종가0.03
일중 범위0.03 - 0.03
52주 범위0.02 - 0.07
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

WALDW 소개

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, th...

[더 보기]
산업
섹터
IPO 일자 May 19, 2021
직원 수 367
상장 거래소 NasdaqCM
티커 WALDW
웹사이트 https://www.waldencast.com
전체 기업 정보

재무 실적

2025년 Waldencast의 매출은 272.07M로, 전년 273.87M 대비 -0.66% 감소했습니다. 순이익은 -229.75M로, 441.31% 증가했습니다.

재무제표
news image

3개월 전 · Simply Wall St.

How Waldencast (WALD) Story Is Shifting As Targets Fall And Brand Hopes Persist

The fair value estimate for Waldencast has been reset from US$3.08 to US$1.87 per share, putting the recent round of reduced price targets into clear focus. This shift sits alongside research that sep...

news image

4개월 전 · MT Newswires

Top Premarket Gainers

Waldencast (WALD) shares were up 31% in Wednesday premarket activity, a day after the company said t

news image

4개월 전 · Simply Wall St.

Promising Penny Stocks To Consider In April 2026

The market has climbed 3.0% in the last 7 days and an impressive 26% over the past year, with earnings projected to grow by 16% annually in the coming years. For those looking to invest in smaller or ...

news image

11개월 전 · StockStory

Why BeautyHealth (SKIN) Stock Is Trading Lower Today

Shares of skincare company BeautyHealth (NASDAQ:SKIN) fell 7.8% in the morning session after a key competitor, Waldencast, announced it received FDA approval for its Obagi saypha MagIQ injectable hyal...